Editas Medicine, Inc.
EDIT
$1.28
$0.010.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -58.64% | 150.95% | 247.03% | 204.54% | 296.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -58.64% | 150.95% | 247.03% | 204.54% | 296.34% |
| Cost of Revenue | -2.15% | 26.55% | 20.45% | -7.67% | -14.04% |
| Gross Profit | -58.91% | 1.74% | 17.83% | 39.49% | 53.45% |
| SG&A Expenses | 3.35% | -4.23% | -10.00% | -11.03% | -1.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.68% | 24.44% | 19.00% | 2.28% | 0.67% |
| Operating Income | -41.22% | -9.52% | 1.39% | 18.11% | 25.13% |
| Income Before Tax | -54.74% | -7.94% | 6.00% | 24.12% | 30.49% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -54.74% | -7.94% | 6.00% | 24.12% | 30.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.74% | -7.94% | 6.00% | 24.12% | 30.49% |
| EBIT | -41.22% | -9.52% | 1.39% | 18.11% | 25.13% |
| EBITDA | -42.91% | -9.95% | 1.21% | 18.45% | 25.73% |
| EPS Basic | -39.94% | 5.47% | 20.53% | 33.94% | 35.88% |
| Normalized Basic EPS | -34.01% | 6.20% | 21.20% | 34.57% | 36.49% |
| EPS Diluted | -39.94% | 5.47% | 20.53% | 33.94% | 35.92% |
| Normalized Diluted EPS | -34.01% | 6.20% | 21.20% | 34.57% | 36.49% |
| Average Basic Shares Outstanding | 8.46% | 12.97% | 17.92% | 15.11% | 10.56% |
| Average Diluted Shares Outstanding | 8.46% | 12.97% | 17.92% | 15.11% | 10.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |